HRP20200585T1 - Poboljšani test za dijagnozu alergije na kikiriki - Google Patents

Poboljšani test za dijagnozu alergije na kikiriki Download PDF

Info

Publication number
HRP20200585T1
HRP20200585T1 HRP20200585TT HRP20200585T HRP20200585T1 HR P20200585 T1 HRP20200585 T1 HR P20200585T1 HR P20200585T T HRP20200585T T HR P20200585TT HR P20200585 T HRP20200585 T HR P20200585T HR P20200585 T1 HRP20200585 T1 HR P20200585T1
Authority
HR
Croatia
Prior art keywords
ara
seq
antibody
isotype
antibodies
Prior art date
Application number
HRP20200585TT
Other languages
English (en)
Inventor
Waltraud Suer
Stefanie Rohwer
Bettina BRIX
Alf WEIMANN
Yvonne WEIMANN
Marco KLINGE
Original Assignee
Euroimmun Medizinische Labordiagnostika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17000245.5A external-priority patent/EP3244212A1/en
Application filed by Euroimmun Medizinische Labordiagnostika Ag filed Critical Euroimmun Medizinische Labordiagnostika Ag
Publication of HRP20200585T1 publication Critical patent/HRP20200585T1/hr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415Assays involving biological materials from specific organisms or of a specific nature from plants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Rehabilitation Therapy (AREA)

Claims (15)

1. Dijagnostički koristan nosač koji sadrži sredstvo za specifično hvatanje protutijela na epitop C-terminalnog kraja Ara h 7 izotipa 7.0201, pri čemu C-terminalni kraj sadrži SEQ ID NO 6 i pri čemu epitop sadrži SEQ ID NO 8, u uzorku od subjekta, pri čemu je nosač odabran iz skupine koja sadrži kuglice, test traku, mikrotitarsku ploču, microarray, čvrsti polimer dobiven iz celuloze, blot iz skupine koja sadrži line blot i dot blot, staklenu površinu, klizač i biočip, te je najpoželjnije mikrotitarska ploča ili line blot, pri čemu je sredstvo za specifično hvatanje protutijela polipeptid koji sadrži ili obuhvaća antigen na koji se veže protutijelo koje se treba uhvatiti ili detektirati ili njegova varijanta koja ima aktivnost vezanja protutijela.
2. Dijagnostički koristan nosač prema patentnom zahtjevu 1, naznačen time što nosač nadalje sadrži sredstvo za specifično hvatanje protutijela na jedan ili više daljnjih antigena iz skupine koja sadrži Ara h 2, Ara h 6, Ara h 1, Ara h 3, Ara h 9, Ara h 8 i Ara h 5, poželjnije iz skupine koja sadrži Ara h 2, Ara h 6, Ara h 1, Ara h 3, Ara h 9, poželjnije protutijelo na Ara h 2 i/ili protutijelo na Ara h 6, najpoželjnije protutijelo na Ara h 2.
3. Komplet naznačen time što sadrži dijagnostički koristan nosač prema bilo kojem od patentnih zahtjeva 1 do 2, kao i sredstvo za specifično otkrivanje uhvaćenog protutijela.
4. Komplet prema patentnom zahtjevu 3, naznačen time što sredstvo za specifično hvatanje protutijela na epitop C-terminalnog kraja Ara h 7 izotipa 7.0201 pri čemu se C-terminalni kraj sastoji od SEQ ID NO 6 i pri čemu epitop sadrži SEQ ID NO 8, te je sredstvo za specifično hvatanje protutijela na jedan ili više daljnjih antigena na odvojenim nosačima ili pri čemu sredstvo za specifično hvatanje protutijela na epitop C-terminalnog kraja Ara h 7 izotipa 7.0201 gdje C-terminalni kraj sadrži SEQ ID NO 6 i pri čemu epitop sadrži SEQ ID NO 8, te je sredstvo za specifično hvatanje protutijela na jedan ili više daljnjih antigena vezano na jednom, poželjno kovalentno vezano na jednom nosaču.
5. Postupak za dijagnozu alergije na kikiriki naznačen time što obuhvaća korak otkrivanja u uzorku od subjekta prisutnosti protutijela na epitopu C-terminalnog kraja Ara h 7 izotipa 7.0201, pri čemu C-terminalni kraj sadrži SEQ ID NO 6 i pri čemu epitop sadrži SEQ ID NO 8.
6. Postupak prema patentnom zahtjevu 5, naznačen time što nadalje obuhvaća korak otkrivanja u uzorku subjekta prisutnosti protutijela na jednom ili više daljnjih antigena, poželjno odabranih iz skupine koja sadrži Ara h 2, Ara h 6, Ara h 1, Ara h 3, Ara h 9, Ara h 8 i Ara h 5, poželjnije iz skupine koja sadrži Ara h 2, Ara h 6, Ara h 1, Ara h 3 i Ara h 9, najpoželjnije Ara h 2 i/ili Ara h 6.
7. Postupak prema bilo kojem od patentnih zahtjeva 5 do 6, naznačen time što se istovremeno određuje prisutnost protutijela na epitopu C-terminalnog kraja Ara h 7 izotipa 7.0201 koji sadrži SEQ ID NO 8 i prisutnost protutijela na jednom ili više daljnjih antigena, poželjno Ara h 2 i/ili Ara h 6.
8. Postupak prema bilo kojem od patentnih zahtjeva 5 do 7, naznačen time što se prisutnost protutijela na epitopu C-terminalnog kraja Ara h 7 izotipa 7.0201 koji sadrži SEQ ID NO 8 i prisutnost protutijela na jednom ili više daljnjih antigena određuju u prostorno odvojenim reakcijama vezivanja.
9. Postupak prema bilo kojem od patentnih zahtjeva 5 do 8, naznačen time što se prisutnost protutijela na epitopu C-terminalnog kraja Ara h 7 izotipa 7.0201 koji sadrži SEQ ID NO 8 i prisutnost protutijela na jednom ili više daljnjih antigena određuju reakcijom u jednoj posudi.
10. Nosač, komplet ili postupak prema bilo kojem od patentnih zahtjeva 1 do 9, naznačen time što je protutijelo na izotipu 7.0201 protutijelo monospecifično prema SEQ ID NO 6, poželjnije prema sekvenci iz skupine koja sadrži SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9 i SEQ ID NO 10, najpoželjnije SEQ ID NO 8.
11. Uporaba polipeptida koji sadrži SEQ ID NO 8, poželjnije sekvence iz skupine koja sadrži SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9 i SEQ ID NO 10, poželjnije SEQ ID NO 6, najpoželjnije Ara h 7 izotip 7.0201 ili njegova varijanta koja se veže na protutijelo na Ara h 7 izotip 7.0201 od subjekta alergičnog na kikiriki, pri čemu je polipeptid rekombinantni, imobilizirani pročišćeni ili fuzijski protein, poželjno pročišćeni i rekombinantni i imobilizirani, te nosača prema bilo kojem od patentnih zahtjeva 1 do 2 ili kompleta prema bilo kojem od patentnih zahtjeva 3 do 4 naznačena time što je za povećanje osjetljivosti dijagnoze alergije na kikiriki.
12. Uporaba polipeptida koji sadrži SEQ ID NO 8, poželjnije sekvence iz skupine koja sadrži SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9 i SEQ ID NO 10, poželjnije SEQ ID NO 6, najpoželjnije Ara h 7 izotip 7.0201 ili njegova varijanta koja se veže na protutijelo na Ara h 7 izotip 7.0201 od subjekta alergičnog na kikiriki, pri čemu je polipeptid rekombinantni, imobilizirani pročišćeni ili fuzijski protein, poželjno pročišćeni i rekombinantni i imobilizirani, naznačena time što je za proizvodnju kompleta za dijagnozu alergije na kikiriki.
13. Uporaba prema bilo kojem od patentnih zahtjeva 11 do 12, naznačena time što je polipeptid koji sadrži SEQ ID NO 8, poželjnije sekvencu iz skupine koja sadrži SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9 i SEQ ID NO 10, poželjnije SEQ ID NO 6, najpoželjnije Ara h 7 izotip 7.0201 ili njegova varijanta koja se veže na protutijelo na Ara h 7 izotip 7.0201 od subjekta alergičnog na kikiriki u pripravku koji sadrži navedeni polipeptid i Ara h 2 i/ili Ara h 6 ili njegovu varijantu koja se veže na protutijelo na Ara h 2 ili Ara h 6 od subjekta alergičnog na kikiriki, redom.
14. Protutijelo, poželjno protutijelo razreda IgE, IgG1 i IgG4, koje se specifično veže za SEQ ID NO 6, poželjnije na sekvencu iz skupine koja sadrži SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9 i SEQ ID NO 10, najpoželjnije na SEQ ID NO 8, pri čemu je poželjno protutijelo izolirano.
15. Uporaba protutijela prema patentnom zahtjevu 14 naznačena time što je za dijagnozu alergije na kikiriki ili za proizvodnju kompleta za dijagnozu alergije na kikiriki.
HRP20200585TT 2017-02-15 2020-04-10 Poboljšani test za dijagnozu alergije na kikiriki HRP20200585T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17000245.5A EP3244212A1 (en) 2017-02-15 2017-02-15 An improved assay for the diagnosis of peanut allergy
EP17001081 2017-06-26
EP18156555.7A EP3364193B1 (en) 2017-02-15 2018-02-13 Improved assay for the diagnosis of peanut allergy

Publications (1)

Publication Number Publication Date
HRP20200585T1 true HRP20200585T1 (hr) 2020-07-10

Family

ID=61163617

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200585TT HRP20200585T1 (hr) 2017-02-15 2020-04-10 Poboljšani test za dijagnozu alergije na kikiriki

Country Status (15)

Country Link
US (1) US10871493B2 (hr)
EP (1) EP3364193B1 (hr)
JP (1) JP6940427B2 (hr)
KR (1) KR102228185B1 (hr)
CN (2) CN113777325A (hr)
AU (1) AU2017279647B2 (hr)
BR (1) BR102017026619A2 (hr)
CA (1) CA2992044C (hr)
ES (1) ES2788389T3 (hr)
HK (1) HK1263291A1 (hr)
HR (1) HRP20200585T1 (hr)
LT (1) LT3364193T (hr)
PL (1) PL3364193T3 (hr)
SI (1) SI3364193T1 (hr)
WO (1) WO2018149927A1 (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201223256D0 (en) 2012-12-21 2013-02-06 Microtest Matrices Ltd Immunoassay
CN112142836A (zh) * 2019-06-28 2020-12-29 中国食品发酵工业研究院有限公司 一种原肌球蛋白抗原的表位肽及其应用
CN112986578B (zh) * 2021-02-04 2023-03-10 南昌大学 一种用于血清特异性Ig E筛查的试纸条及其制备方法
EP4057009A1 (en) 2021-03-08 2022-09-14 Euroimmun Medizinische Labordiagnostika AG Methods and reagents for detecting an antibody to a sesame nsltp
EP4134674A1 (en) 2021-08-13 2023-02-15 Euroimmun Medizinische Labordiagnostika AG Methods and reagents for detecting an antibody to a ses ipr-10 allergen
WO2023190098A1 (ja) * 2022-03-31 2023-10-05 日本ハム株式会社 落花生アレルゲンの検査用キットおよび検査方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5043077Y2 (hr) 1973-12-03 1975-12-09
DE69922293T2 (de) 1998-06-09 2005-12-01 Fuji Photo Film Co., Ltd., Minami-Ashigara Verfahren zur Kontrolle der Produktion einer mit einer Linse versehenen Photofilmeinheit
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
AU2003208817A1 (en) 2002-02-27 2003-09-09 Merck Patent Gmbh Method for producing hypoallergenic major birch pollen allergens rbet v 1
ATE307141T1 (de) 2003-01-21 2005-11-15 Biomay Prod & Handel Verfahren zur vorbereitung von hypoallergenen mosaikproteine
EP1731907B1 (en) 2004-03-05 2010-10-13 Prima Meat Packers, Ltd. Method of detecting allergen
US20060115499A1 (en) 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
EP2694966A4 (en) * 2011-03-20 2014-12-24 Univ Colorado Regents METHOD FOR PREDICTING THE GRAVITY OF AN ALLERGIC REACTION
DE202011106093U1 (de) 2011-09-24 2011-10-19 Euroimmun Medizinische Labordiagnostika Ag Kalibrationsstreifen für einen Immunoblot
DK3482771T3 (da) 2013-03-14 2023-03-20 Nestle Sa Fremstilling af jordnøddeformuleringer til oral desensibilisering
WO2014182932A1 (en) * 2013-05-08 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Methods of testing for allergen sensitivity
US9688977B2 (en) * 2013-08-05 2017-06-27 Greenlight Biosciences, Inc. Engineered phosphoglucose isomerase proteins with a protease cleavage site
CN103554245B (zh) * 2013-10-15 2014-12-31 北京大学 一种融合标签蛋白
EP3256158A4 (en) * 2015-02-13 2018-11-07 Virtici, LLC Tolerance therapeutic for treating polypeptide induced allergy
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂a及過敏原調配物
EP3088414A1 (de) 2015-04-30 2016-11-02 Euroimmun Medizinische Labordiagnostika AG Verbesserter nachweis von nussallergien
EP3196209B1 (en) 2016-01-25 2019-10-23 Euroimmun Medizinische Labordiagnostika AG A macadamia allergen

Also Published As

Publication number Publication date
EP3364193A1 (en) 2018-08-22
PL3364193T3 (pl) 2020-11-02
CN108427001A (zh) 2018-08-21
JP6940427B2 (ja) 2021-09-29
KR20180094487A (ko) 2018-08-23
SI3364193T1 (sl) 2020-07-31
KR102228185B1 (ko) 2021-03-18
CN113777325A (zh) 2021-12-10
US10871493B2 (en) 2020-12-22
CN108427001B (zh) 2021-10-15
ES2788389T3 (es) 2020-10-21
HK1263291A1 (zh) 2020-03-27
CA2992044C (en) 2021-10-19
BR102017026619A2 (pt) 2018-10-30
WO2018149927A1 (en) 2018-08-23
AU2017279647A1 (en) 2018-08-30
AU2017279647B2 (en) 2022-05-26
CA2992044A1 (en) 2018-08-15
EP3364193B1 (en) 2020-04-01
US20180231567A1 (en) 2018-08-16
JP2018132525A (ja) 2018-08-23
LT3364193T (lt) 2020-06-10

Similar Documents

Publication Publication Date Title
HRP20200585T1 (hr) Poboljšani test za dijagnozu alergije na kikiriki
AU2018264112B2 (en) Methods and compositions for detecting multiple analytes with a single signal
US9588117B2 (en) Detecting cells secreting a protein of interest
US10598657B2 (en) Immunoassay utilizing trapping conjugate
JP2011528905A (ja) 抗体レパートリーアレイ(ara)を使用する標的特異的抗体を発見するための方法および組成物
WO2004005477A3 (en) Protein microarrays on mirrored surfaces for performing proteomic analyses
JPWO2009148150A1 (ja) インフルエンザウィルス検出用デバイス
JP2013511530A5 (hr)
US20110020840A1 (en) Method and kits for detecting antibodies against therapeutic antibodies
KR102671155B1 (ko) Ns1 단백질의 결합 단백질
RU2013142334A (ru) КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ ДЛЯ ОПРЕДЕЛЕНИЯ НЕ4а
WO2004094458A2 (en) Major histocompatibility complex (mhc)-peptide arrays
JP2014518624A5 (hr)
Ch’ng et al. Phage display-derived antibodies: Application of recombinant antibodies for diagnostics
JP2009517015A5 (hr)
WO2008035527A1 (fr) ANTICORPS MONOCLONAL ANTI-C1q
JP2011505390A (ja) リウマチ性関節炎自己抗体との免疫反応性合成ペプチド
JP2008255046A (ja) 融合タンパク質、これを用いた抗体捕捉担体および抗原検出法
WO2017125007A1 (zh) 用于诊断活动性结核的方法和试剂盒
CN116120440A (zh) 抗SARS-CoV-2刺突蛋白S1的单克隆抗体及其应用
KR102339334B1 (ko) 인간 메타뉴모바이러스(hMPV)의 항원 M의 특이적 단클론 항체 및 진단 방법에 있어서의 그 용도
CN117720650B (zh) 抗人呼吸道合胞病毒抗体及其应用
JP6245688B2 (ja) IgY特異的結合ペプチド及びそれによるIgYの精製法
JP7416485B2 (ja) スイッチング結合剤、その製造方法、及びそれを用いた薬学組成物、検査キット及び抗原と抗体との分析方法
CN117720650A (zh) 抗人呼吸道合胞病毒抗体及其应用